EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oxymatrine Inhibits Epithelial‐Mesenchymal Transition to Alleviate Airway Remodeling in Chronic Obstructive Pulmonary Disease by Suppressing the TGF ‐β1/Smad Pathway

Shuang Zhou, Ju-Xiang Zhu, Jing Li iD

The Kaohsiung Journal of Medical Sciences · 2025

DOI: 10.1002/kjm2.70118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Shuang Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Diseases, Xiangyang Traditional Chinese Medicine Hospital (Xiangyang Institute of Traditional Chinese Medicine), Xiangyang, H…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Pulmonary Disease, Chronic Obstructive, Transforming Growth Factor beta1, Quinolizines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explored the therapeutic efficacy of oxymatrine (OMT, C 15 H 24 N 2 O 2 ) in a murine model of cigarette smoke (CS)‐induced chronic obstructive pulmonary disease (COPD) and elucidated its underlying mechanisms. A COPD model was established in mice through prolonged exposure to CS, followed by intraperitoneal administration of OMT (50 mg/kg) over 3 months. Lung inflammation and fibrosis were evaluated using histopathological techniques (hematoxylin–eosin and Masson staining), enzyme‐linked immunosorbent assays (ELISA), and pulmonary function tests. The expression of epithelial‐mesenchymal transition (EMT) markers and components of the transforming growth factor‐β1 (TGF‐β1)/Smad signaling pathway were assessed via Western blot and immunofluorescence. In vitro, human bronchial epithelial (HBE) cells were exposed to CS extract (CSE, 10% v/v) or TGF‐β1 (10 ng/mL), with or without treatment using OMT (80 μM) or the TGF‐β receptor I inhibitor SB525334 (10 μM). Cell viability, EMT marker expression, and Smad2/3 phosphorylation were measured. In vivo, OMT significantly reduced CS‐induced airway inflammation, as evidenced by decreased inflammatory cell infiltration and lower proinflammatory cytokines in bronchoalveolar lavage fluid. OMT treatment improved lung function by restoring compliance, reducing airway resistance, and enhancing forced expiratory capacity. Similarly, OMT alleviated CS‐induced pulmonary fibrosis and EMT, as shown by decreased collagen deposition and normalization of EMT marker expression (E‐cadherin, vimentin, and α‐smooth muscle actin [α‐SMA]) in lung tissues. In HBE cells, OMT counteracted EMT induced by CSE or TGF‐β1, significantly suppressing Smad2/3 phosphorylation and nuclear translocation. Mechanistic analysis revealed that OMT inhibited activation of the TGF‐β1/Smad signaling pathway in both in vivo and in vitro models. Moreover, combining OMT and SB525334 increased EMT suppression in CSE‐exposed HBE cells. Importantly, safety evaluations showed no histopathological abnormalities in major organs following OMT administration. In conclusion, these findings indicate that OMT mitigates COPD progression by targeting the TGF‐β1/Smad pathway, supporting its potential as a safe and effective therapeutic option for COPD management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionPulmonary Disease, Chronic ObstructiveTransforming Growth Factor beta1QuinolizinesAlkaloidsAirway RemodelingAnimalsHumansSignal TransductionMiceSmad2 ProteinMaleSmad3 ProteinDisease Models, AnimalCell LineMice, Inbred C57BLLungPhosphorylationMatrines

Stichwörter der Autor:innen

TGF‐β1/Smadchronic obstructive pulmonary diseaseepithelial‐mesenchymal transitioninflammationoxymatrine

Substanzen

Transforming Growth Factor beta1QuinolizinesoxymatrineAlkaloidsSmad2 ProteinSmad3 ProteinMatrines

Autor:innen und Institutionen

  • Department of Pulmonary Diseases, Xiangyang Traditional Chinese Medicine Hospital (Xiangyang Institute of Traditional Chinese Medicine), Xiangyang, Hubei, China.
  • Department of General Medicine, Zhongxiang People's Hospital, Zhongxiang, Hubei, China.

ORCID-Profile: Jing Li

Zitieren

APA

Zhou, S., Zhu, J. X., & Li, J. (2025). Oxymatrine Inhibits Epithelial‐Mesenchymal Transition to Alleviate Airway Remodeling in Chronic Obstructive Pulmonary Disease by Suppressing the TGF ‐β1/Smad Pathway. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70118

Vancouver

Zhou S, Zhu JX, Li J. Oxymatrine Inhibits Epithelial‐Mesenchymal Transition to Alleviate Airway Remodeling in Chronic Obstructive Pulmonary Disease by Suppressing the TGF ‐β1/Smad Pathway. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70118

BibTeX
@article{Zhou2025,
  author = {Zhou, Shuang and Zhu, Ju-Xiang and Li, Jing},
  title = {Oxymatrine Inhibits Epithelial‐Mesenchymal Transition to Alleviate Airway Remodeling in Chronic Obstructive Pulmonary Disease by Suppressing the TGF ‐β1/Smad Pathway},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2025},
  doi = {10.1002/kjm2.70118}
}
Kostenlos starten →